Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs

OBJECTIVE: Despite evidence of effectiveness, pharmacotherapy—methadone, buprenorphine, or naltrexone—is prescribed to less than 35% of Veterans Health Administration (VHA) patients diagnosed with opioid use disorder (OUD).Among veterans whose OUD treatment is provided in VHA residential programs, f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Stud Alcohol Drugs
Main Authors: Finlay, Andrea K., Wong, Jessie J., Ellerbe, Laura S., Rubinsky, Anna, Gupta, Shalini, Bowe, Thomas R., Schmidt, Eric M., Timko, Christine, Burden, Jennifer L., Harris, Alex H. S.
Formato: Artigo
Idioma:Inglês
Publicado em: Rutgers University 2018
Assuntos:
Drug Overdose and Treatment
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308173/
https://ncbi.nlm.nih.gov/pubmed/30573022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15288/jsad.2018.79.909
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados